SMARCA4-DNM2 Fusion FISH Probe
The SMARCA4-DNM2 Fusion FISH Probe is used to confirm a fusion of the SMARCA4 and DNM2 genes. The fusion of the SMARCA4 and DNM2 genes has been associated with Esophageal Carcinoma, and Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SMARCA4-DNM2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SMARCA4-DNM2-20-AQAQ | 20 (40 μL) | 200 μL |
|
DNM2 Gene Summary
Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
Gene Name: Dynamin 2
Chromosome: CHR19: 10828728 -10942586
Locus: 19p13.2
SMARCA4 Gene Summary
The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Gene Name: SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4
Chromosome: CHR19: 11071597 -11172958
Locus: 19p13.2
Gene Diseases
The SMARCA4 DNM2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Esophageal Carcinoma |
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|